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Uncontrollable nociceptive stimulation adversely affects recovery in spinally contused rats.
Spinal cord injury (SCI) results in altered microRNA (miRNA) expression both at, and distal
to the lesion site.We hypothesized that uncontrollable nociception further inﬂuences SCI-
sensitive miRNAs and associated gene targets, potentially explaining the progression of
maladaptive plasticity. Our data validated previously described sensitivity of miRNAs to SCI
alone. Moreover, following SCI, intermittent noxious stimulation decreased expression of
miR124 in dorsal spinal cord 24 h after stimulation and increased expression of miR129-
2 in dorsal, and miR1 in ventral spinal cord at 7 days. We also found that brain-derived
neurotrophic factor (BDNF) mRNA expression was signiﬁcantly down-regulated 1 day after
SCI alone, and signiﬁcantly more so, after SCI followed by tailshock. Insulin-like growth
factor-1 (IGF-1) mRNA expression was signiﬁcantly increased at both 1 and 7 days post-
SCI, and signiﬁcantly more so, 7 days post-SCI with shock. MiR1 expression was positively
and signiﬁcantly correlated with IGF-1, but not BDNF mRNA expression. Further, stepwise
linear regression analysis indicated that a signiﬁcant proportion of the changes in BDNF and
IGF-1 mRNA expression were explained by variance in two groups of miRNAs, implying
co-regulation. Collectively, these data show that uncontrollable nociception which activates
sensorimotor circuits distal to the injury site, inﬂuences SCI-miRNAs and target mRNAs
within the lesion site. SCI-sensitive miRNAs may well mediate adverse consequences of
uncontrolled sensorimotor activation on functional recovery. However, their sensitivity to
distal sensory input also implicates thesemiRNAs as candidate targets for themanagement
of SCI and neuropathic pain.
Keywords: spinal cord injury, microRNA, uncontrollable nociception, BDNF, IGF
INTRODUCTION
Signiﬁcant attention has been given to investigating the central
molecular changes that modulate locomotor recovery and pain
following spinal cord injury (SCI; Boyce and Mendell, 2014; Lerch
et al., 2014; Schwab and Strittmatter, 2014; Silva et al., 2014). How-
ever, surprisingly, there is relatively little information on the role
of afferent peripheral signals in the development of SCI-related
pain or attenuation of locomotor function. Given that SCI rarely
occurs in isolation, but is often accompanied by peripheral tissue
damage and trauma, examining the effects of afferent nocicep-
tive signaling seems warranted. This is further underscored by
previous research in our laboratory suggesting that functional
recovery after SCI is attenuated by peripheral nociceptive stim-
ulation applied below the level of the spinal injury (Grau et al.,
2004). Intermittent noxious stimulation decreased the recovery of
locomotor function, delayed reinstatement of bladder function,
led to greater mortality and spasticity, and increased tissue loss at
the injury site in adult rats (Grau et al., 2004). Further, we found
that nociceptive stimulation rapidly resulted in decreased brain-
derived neurotrophic factor (BDNF) – tropomyosin-receptor
kinase B signaling (Gomez-Pinilla et al., 2007; Garraway et al.,
2011). This signaling pathway has been shown to play a key role
in modulating neuronal plasticity, promoting axonal regenera-
tion, and improving functional recovery following SCI (Xu et al.,
1995; Patterson et al., 1996; McTigue et al., 1998; Kerr et al., 1999;
Garraway et al., 2003; Boyce et al., 2007; Huie et al., 2012b).
The present study focused on identifying intracellular reg-
ulatory molecules that, when activated by nociceptive input,
might inﬂuence neurotrophic signaling pathways and functional
recovery. Speciﬁcally, we hypothesized that miRNAs may be
sensitive to nociceptive stimulation, and activate potentially mal-
adaptive gene networks to further undermine recovery after
SCI. We, and others, have previously shown that SCI leads
to signiﬁcant alterations in miRNA expression (Liu et al., 2009;
Nakanishi et al., 2010; Strickland et al., 2011). Our previous
study showed that miR1, miR124, and miR129 were signiﬁ-
cantly down-regulated following a spinal cord contusion, while
miR146a and miR21 were transiently induced (Strickland et al.,
2011), and that these miRNAs were sensitive to opioid anal-
gesics like morphine (Strickland et al., 2014). These miRNAs
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play important roles in regulating critical gene networks that
have been implicated in the development of hypersensitivity and
may contribute to impaired functional recovery. For example,
though the expression of miR124 is often associated with early
neuronal differentiation (Visvanathan et al., 2007), and neurite
outgrowth (Yu et al., 2008a), miR124 is also important for pro-
moting neuronal survival in the adult (Doeppner et al., 2013).
Moreover, miR124 may play an important role in neuropathic
pain by inhibiting neuro-inﬂammation (Ponomarev et al., 2011;
Kynast et al., 2013) and inﬂammatory hyperalgesia (Willemen
et al., 2012) in the adult. Similarly, miR129-2 promotes cell
cycle arrest, and dysregulation of miR129-2 results in neuronal
death (Di Giovanni et al., 2003; Byrnes et al., 2007; Herrup and
Yang, 2007; Wu et al., 2010). Interestingly, miR1, a member of
the miR1/miR206 family has been shown to regulate important
growth-promoting neurotrophic factors like BDNF (Lewis et al.,
2003; Lee et al., 2012). Modulation of miR1 activity may play
a signiﬁcant role in regulating BDNF signaling after SCI and,
importantly for this study, in mediating the effects of intermit-
tent noxious stimulation on recovery after SCI. To assess this
possibility, the current study investigated the relationship between
SCI-sensitive miRNA expression and intermittent noxious stimu-
lation in tissue collected 1 h, 24 h, and 7 days after stimulation.
We also assessed the relationship between the expression of miR-




The subjects were male Sprague–Dawley rats (Rattus norvegicus)
obtained fromHarlan (Houston, TX,USA). The rats were approx-
imately 90–110 days old (350–400 g), were individually housed in
Plexiglas bins [45.7 (length) × 23.5 (width) × 20.3 (height) cm]
with food and water continuously available, and were maintained
on a 12-h light/dark cycle. All behavioral testing was performed
during the light cycle. To facilitate access to the food and water,
extra bedding was added to the bins after surgery and long mouse
sipper tubes were used so that the rats could reach the water with-
out rearing. All of the experiments were reviewed and approved by
the Institutional Animal Care and Use Committee at Texas A&M
University and all NIH guidelines for the care and use of animal
subjects were followed.
SURGERY
Subjects were anesthetizedwith isoﬂurane (5%, gas). Once a stable
level of anesthesia was achieved, the concentration of isoﬂurane
was lowered to 2–3%. An area extending approximately 4.5 cm
above and below the injury site was shaved and disinfected with
iodine, and a 7.0 cm incision was made over the spinal cord. Next,
two incisions were made on either side of the vertebral column
(approximately 4–5 mm depth), extending about 3 cm rostral and
caudal to the T12 segment. The dorsal spinous processes at T12
vertebral level were removed (laminectomy), and the spinal tissue
exposed. The dura remained intact. For the contusion injury, the
vertebral column was ﬁxed within the MASCIS device (Gruner,
1992; Constantini and Young, 1994), and a moderate injury was
produced by allowing the 10 g impactor (outﬁtted with a 2.5 mm
tip) to drop 12.5 mm. Sham controls received a laminectomy, but
the cord was not contused with the MASCIS device. Following
surgery, the wound was closed with Michel clips. T12 vertebral
level contusion models have been routinely used by members of
our group to deﬁne spinal cord learning circuits and molecular
mechanisms involved with recovery of function (Ferguson et al.,
2008; Brown et al., 2011; Hook et al., 2011). Lesions at this level
result in well-deﬁned and replicable sensory-motor deﬁcits, and
we therefore chose to utilize contusion at this level to also examine
changes in miRNA expression.
To help prevent infection, subjects were treated with 100,000
units/kg Pﬁzerpen (penicillin G potassium) immediately after
surgery and again 2 days later. For the ﬁrst 24 h after surgery,
rats were placed in a recovery room maintained at 26.6◦C. To
compensate for ﬂuid loss, subjects were given 2.5 ml of saline
after surgery. Bladdersweremanually expressed twice daily (morn-
ing and evening) until the animals had empty bladders for three
consecutive days, at the times of expression.
UNCONTROLLABLE INTERMITTENT NOXIOUS STIMULATION
Intermittent shock was applied 24 h after surgery while subjects
were loosely restrained in Plexiglas tubes as previously described
(Crown et al., 2002; Grau et al., 2004). Electrical stimulation was
applied through cutaneous electrodes coated with electrode gel
(HarvardApparatus,Holliston,MA,USA) and attached 2 cm from
the tip of the tail with Orthaleic tape. Leads from the electrodes
were attached to a shock generator (BRS/LVE,Model SG-903, Lau-
rel,MD,USA), and intermittent constant current 1.5mA,electrical
stimulation was applied through the electrodes. Rats treated with
uncontrollable intermittent stimulation received 180, 80-ms tail
shocks on a variable time schedule with a mean inter-stimulus
interval of 2 s (range 0.2–3.8 s). Unshocked subjects (contused and
sham operated) were placed in the restraining tubes for the same
amount of time as shock subjects. The unshocked subjects had
the tail electrodes attached, but did not receive the electrical stim-
uli. The number of subjects within each experimental condition is
given Table 1.
RNA EXTRACTION AND qRT-PCR
Animals [SCI/unshocked (SCIunshock) or SCI/shock-exposed
(SCIshock)] were sacriﬁced at 1 h, 1 day, or 7 days following expo-
sure to intermittent shock or control treatment (i.e., 25 h, 48 h,
and 8 days following SCI). All subjects were deeply anesthetized
with pentobarbital (50 mg/kg), and 1 cm of spinal cord around
the lesion epicenter was rapidly removed. To determine the spatial
Table 1 | Number of subjects (n) per condition.
Treatment 1 h 1 day 7 days
Sham operated 4 4 (d and v) 4 (d and v)
Contused-unshocked 6 6 (d and v) 6 (d and v)
Contused-shocked 6 6 (d and v) 6 (d and v)
Tissue collected at 1 and 7 days postsurgery was subdivided into dorsal (d) and
ventral (v) portions and separately analyzed.
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(dorsal–ventral) changes in the expression of miRNAs and genes
of interest, the spinal cord tissue was further subdivided to yield
dorsal and ventral regions in the 1 and 7 days after treatment
groups. The cord was processed for the extraction of total RNA
(RNeasy Mini Kit; Qiagen, Valencia, CA, USA) and subsequently
quantiﬁed using a NanoDrop 2000 Spectrophotometer (Thermo
Scientiﬁc; Wilmington, DE, USA), and stored at −80◦C.
MiRNAexpression datawasmeasuredwith quantitative reverse
transcription (qRT)-PCR for miRNAs, based on the protocol
of the miRCURYTM LNA microRNA Universal RT-PCR system
(EXIQON; Woburn, MA, USA). RNA samples were converted to
cDNA, and qRT-PCR was performed using a 7900HT Fast Real-
Time PCR System (Applied Biosystems, Foster City, CA, USA).
Validated commercially available forward and reverse primers
(EXIQON; Table 2) for hsa-miR124, hsa-miR1, hsa-miR21, hsa-
miR129-2, and hsa-miR146a were used for PCR ampliﬁcation,
and real time data was normalized to U6 small nuclear RNA
(U6SNR). Similarly, mRNA expression of BDNF and IGF-1 was
measured using qRT-PCR for mRNAs, based on the protocol for
PerfeCTa® SYBR® Green SuperMix with ROXTM (Quanta Bio-
sciences; Gaithersburg, MD, USA). RNA samples were converted
to cDNA using qScriptTM cDNA SuperMix (Quanta Biosciences;
Gaithersburg, MD, USA), and qRT-PCR was performed using a
7900HT Fast Real-Time PCR System (Applied Biosystems, Fos-
ter City, CA, USA). Forward and reverse primers (Integrated
DNA Technologies; Coralville, IA, USA) for BDNF and IGF-1
were used for PCR ampliﬁcation (Table 2), and real time data
was normalized using glyceraldehyde 3-phosphate dehydrogenase
(GAPDH). Three technical replicates were averaged per sample.
Selection criteria for non-commercially provided mRNA primer
pairs were the identiﬁcation of a single amplicon and efﬁcien-
cies based on serial cDNA dilution according to our previously
published protocols (Camarillo and Miranda, 2008). Efﬁciency
for mRNA primers was 100.4% for BDNF, 99.71% for IGF-1
and 100.06% for GAPDH. Normalization controls were utilized
as reported previously (Strickland et al., 2011, 2014), and there
were no statistical differences in the expression of either U6SNR or
GAPDH with treatment condition or spinal cord region. Relative
miRNA and mRNA expression was determined by calculating the
meandifference between cycle threshold of either themiRNA from
the U6SNR normalization control, or the BDNF/IGF-1 mRNA
from the GAPDH normalization control for each sample (
cycle threshold (CT)) within each sample group (samples with
same miRNA ID, time, and condition parameters) and expressed
as −CT for relative change in expression. Sample means that
were greater than ±2 SDs from the mean CT were considered
outliers and removed from the analysis. As indicated inTable 1, the
experimental design yielded 80 samples and for each, seven miR-
NAs were assessed, yielding a total of 560 data points. Our criteria
identiﬁed just 30 data points for exclusion (approximately 5.4%),
and no more than one data point in any individual experimental
group was excluded. Fold change in miRNA/mRNA expression
was determined by calculating the difference between the mean
CT for the sham control and individual sample CTs of sham,
SCI/unshocked (SCIunshock), and SCI/shock-exposed (SCIshock)
sample groups at the same time point (−CT), and expressed
as mean fold-change (2−CT; Livak and Schmittgen, 2001).
DATA ANALYSIS
All data were analyzed using SPSS software version 18 (SPSS;
Chicago, IL, USA). MicroRNA expression, veriﬁed by qRT-PCR,
was analyzed by multivariate analysis of variance (ANOVA) using
Pillai’s trace statistic, and further analyzed using post hoc univari-
ate ANOVA and Fisher’s least signiﬁcant difference (LSD) test.
Other data were analyzed using ANOVAs followed by post hoc f-
LSD using planned comparisons to limit the number of post hoc
comparisons. In all cases, the a priori α value was set at 0.05.
Data were expressed as mean ± SEM, as indicated in the ﬁgure
legends.
Correlations between expression of miRNAs, and between
miRNA and either BDNF or IGF-1 mRNA expression, were deter-
mined by Pearson’s product–moment correlation using –CT
values of either the miRNAs or BDNF/IGF-1 as separate inde-
pendent variables. The a priori α value was set at 0.05, and
data were expressed as the mean difference in cycle threshold
change of either each miRNA relative to the cycle threshold of
U6 controls (−CT = CTU6 − CTmiRNA), or BDNF or IGF-
1 expression relative to the cycle threshold of GAPDH controls
(−CT = CTGAPDH –CTmRNA). Additionally, stepwise linear
regression analyses were performed on Pearson’s correlation data
Table 2 | Primer sequences.








hsa-miR-129-2-3p/# 204026 AAGCCCUUACCCCAAAAAGCAU MIMAT0004605
hsa-miR-146a-5p/# 204688 UGAGAACUGAAUUCCAUGGGUU MIMAT0000449
U6 snRNA/# 203907
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between miRNA and either BDNF or IGF-1 mRNA expression
to determine which miRNAs contributed to the signiﬁcant cor-
relations. BDNF or IGF-1 mRNA expression was the dependent
variable, while miRNA expression was the independent variable,
and the a priori α value was set at 0.05 for model signiﬁcance.
RESULTS
QUANTIFICATION OF SHOCK-INDUCED CHANGES IN miRNA
EXPRESSION
Contused rats exhibited increased miR21 and miR146a expression
1 h after shock treatment
We previously reported that miR1, miR21, miR124, miR129-2,
and miR146a were signiﬁcantly affected by a spinal cord contu-
sion (Strickland et al., 2011). To determinewhether uncontrollable
intermittent noxious stimulation affects these SCI-sensitive miR-
NAs, their expression was determined by qRT-PCR in sham
controls and in contused animals following either no shock
exposure (SCIunshock) or uncontrollable intermittent tailshock
(SCIshock). Initially, we analyzed miRNA expression within the
whole spinal cord segment (combined dorsal and ventral spinal
cord) at the lesion site at 1 h following intermittent nox-
ious stimulation (25 h after contusion surgery). Both miR21
[F(2,13) = 15.4, p < 0.0003] and miR146a [F(2,13) = 6.2,
p < 0.01] were signiﬁcantly increased following SCI (all post
hoc comparisons relative to sham control, p < 0.02), and
exposure to intermittent tail shock did not result in further
alterations of miRNA expression (Figure 1). MiR1, miR124,
and miR129-2 were not signiﬁcantly altered at the lesion site,
either by contusion or by intermittent tail-shock at 1 h post-
stimulation.
A contusion injury down-regulated expression of miR1, miR124,
mi129-2, and up-regulated miR21, 1–7 days after treatment
We microdissected the 1 cm of spinal cord tissue bracketing the
injury segment to yield dorsal/sensory and ventral/motor regions
in the 1 and 7 days treatment groups. Microdissection of the cord
provides additional information on the spatial (dorsal–ventral)
and functional relevance (sensory-motor) of changes in SCI-
sensitive miRNA expression. We hypothesized that SCI-induced
expression changes of some trauma-sensitive miRNAs would
exhibit spatial and functional speciﬁcity, and that uncontrollable
nociception might exacerbate these changes. miRNA expression
in contused rats was signiﬁcantly altered by exposure to shock and
the pattern of expression depended upon both time and region
(dorsal versus ventral). Preliminary analyses using a multivariate
ANOVA of qRT-PCR data conﬁrmed that there was a signiﬁ-
cant main effect of time [Pillai’s Trace Statistic, F(5,33) = 20.89;
p < 0.001], treatment [F(10,68) = 6.44; p < 0.001], and spinal
region (dorsal/ventral) [F(5,33) = 8.31; p < 0.001], as well as a
three-way statistically signiﬁcant interaction between time, treat-
ment, and spinal region [F(10,68) = 2.59; p < 0.01]. Post hoc
univariate ANOVAs indicated a main effect of time on miR1,
miR21, miR124, and miR146a, a main effect of treatment on
miR1, miR21, miR124, and miR129-2, and a main effect of spinal
region on miR1 and miR146a (all Fs > 9.14, p < 0.005). There
was also a signiﬁcant interaction effect of time and treatment on
miR124 expression, and of time, treatment, and spinal region
on miR1, miR129-2, and miR146a (all Fs > 3.68, p < 0.05).
An effect of time emerged because expression generally declined
across days. miR1 and miR146a exhibited an overall difference
across spinal regions because expression was somewhat less in the
ventral portion.
Post hoc LSD t-tests were used to further analyze the effect of
treatment. We found that miR1, miR124, and miR129-2 expres-
sion was signiﬁcantly decreased following spinal cord trauma,
irrespective of exposure to uncontrollable intermittent tailshock
(pmiR1 < 0.001, pmiR124 < 0.001, and pmiR129−2 < 0.001; Figures 2
and 3). In contrast, miR21 expression was up-regulated in con-
tused subjects (pmiR21 < 0.001), and there was no change in the
expression of miR146a.
Intermittent tailshock produces a selective increase in
mR1/miR129-2 and a decrease in miR124 in contused rats
The effect of shock treatment also depended upon region and
time (Figures 2 and 3). The SCIshock rats alone exhibited a
signiﬁcant down-regulation of miR1 and miR124 in the dor-
sal region of the spinal cord at 7 days posttreatment. Post hoc
planned comparisons also indicated that the contusion injury
per se decreased the expression of miR1 in the ventral/motor
tissue, but this effect was signiﬁcantly attenuated by uncontrol-
lable shock; expression of miR1 was increased in the SCIshock
group compared with SCIunshock treatment. Similarly, there was
a signiﬁcant increase in the expression of miR129-2 in dor-
sal/sensory tissue at 7 days following SCIshock treatment relative
to SCIunshock treatment (p < 0.05; Figure 3), and a signiﬁcant
decrease in the expression of miR124 in dorsal/sensory tissue at
1 day following SCIshock relative to SCIunshock treatment (p < 0.01;
Figure 2).
Correlation analyses indicated signiﬁcant relationships between
expression changes within distinct groups of SCI-sensitive miRNAs
Given miRNA dysregulation following both contusion injury and
uncontrollable nociception, we hypothesized that statistical rela-
tionships might exist between expression changes of different
SCI-sensitive miRNAs, indicative of possible co-regulation. Pear-
son’s product–moment correlations indicated three groups of
signiﬁcant correlations between miRNAs (Figures 4A,B; Table 3).
In combined analysis of data obtained from both dorsal and
ventral spinal cord, and at both 1 and 7 days, there were signiﬁ-
cant correlations between miR1 and miR21, miR124, miR129-2,
and miR146a (Figure 4A), between miR124 and miR1, miR129-
2, and miR146a, and between miR146a and miR1, miR21,
and miR124 (for all Pearson’s rs, p < 0.05, see Table 3;
Figure 4B).
INTERMITTENT SHOCK SENSITIVITY OF miRNA TARGET GENES IN
CONTUSED RATS
Contused rats exhibited a decrease in IGF-1 expression at 1 h
As miR1 is further modiﬁed by uncontrollable intermittent tail-
shock following contusion,we assessed the extent towhich changes
in miR1 expression corresponded to modulation of potential
neurotrophin and growth factor mRNA targets. Based on prior
work (Lewis et al., 2003; Yu et al., 2008b; Lee et al., 2012; Li
et al., 2012), we assayed BDNF and IGF-1 mRNA expression by
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FIGURE 1 | Bar graphs depicting qRT-PCR analysis of miRNA
expression of miR1, miR21, miR124, miR129-2, and miR146a at the
lesion site for sham animals and after unshocked or shock
treatment in contused animals at 1 h following tailshock treatment.
The x -axis denotes treatment condition, and the y -axis denotes the log
of mean fold expression change of miRNA. Data are normalized relative
to U6 small nuclear RNA internal gene expression and expressed as the
mean of all fold changes of individual samples within a treatment group
relative to the mean of the treatment group, with asterisks indicating
signiﬁcance (LSD) compared with sham controls; p values are as
indicated in the text. The error bars indicate the standard error of the
mean (SEM).
qRT-PCR in sham controls and in response to either no shock
exposure or uncontrollable intermittent tailshock following injury.
As with the miRNA expression analysis, we ﬁrst analyzed mRNA
expression in full segments (dorsal + ventral) at 1 h follow-
ing treatment. Planned comparisons indicated that there was a
signiﬁcant decrease in expression of IGF-1 following the contu-
sion injury, irrespective of uncontrollable intermittent tailshock
(Student’s two-tailed t-test, punshock < 0.01 and pshock < 0.005;
Figure 5A).
A contusion injury down-regulated expression of BDNF and
up-regulated IGF-1 mRNA expression
Subsequently, spatial expression (dorsal/sensory–ventral/motor)
of BDNF and IGF-1 mRNA was assessed at 1 and 7 days following
SCIunshock or SCIshock treatment. A multivariate ANOVA of
the qRT-PCR data indicated a signiﬁcant main effect of time
[Pillai’s Trace Statistic, F(2,51) = 5.20; p < 0.01], treatment
[F(4,104) = 11.66; p < 0.001], and spinal region (dorsal/ventral)
[F(2,51) = 17.97; p < 0.001], and a signiﬁcant interaction effect
between both time and treatment [F(4,104) = 6.29; p < 0.001],
and treatment and spinal region [F(4,104) = 2.56; p < 0.05]. Post
hoc univariate ANOVAs indicated a main effect of time on IGF-
1 mRNA, a main effect of treatment on both BDNF and IGF-1
mRNAs, and a main effect of spinal region on BDNF mRNA (all
Fs> 9.49, p< 0.005). For IGF-1 and BDNFmRNA expression, the
effect of treatment depended on time (both Fs > 7.95; p < 0.001).
In addition, for BDNF the effect of treatment depended upon
spinal region as well as time (all Fs > 4.03; p < 0.05).
Post hoc LSD t-tests indicated that BDNF mRNA was signiﬁ-
cantly decreased, while IGF-1 mRNA was signiﬁcantly increased
following spinal cord trauma, (p < 0.001; Figures 5B,C).
Intermittent tailshock reduces BDNF expression in the dorsal region
a day after treatment and increases IGF-1 expression at 7 days
following treatment
Post hoc planned comparisons indicated that there was a signiﬁ-
cant decrease in expression of BDNF in dorsal/sensory tissue of
SCIshock subjects relative to SCIunshock at 1 day following tailshock
(p < 0.05; Figure 5B). In contrast, shock treatment increased
expression of IGF-1 mRNA in ventral/motor tissue at 7 days fol-
lowing SCIunshock or SCIshock treatment (p< 0.05; Figure 5C). Post
hoc planned comparisons also indicated signiﬁcant spatial changes
(dorsal/sensory relative to ventral/motor) in mRNA expression,
including increased relative dorsal/sensory expression of BDNF
in sham, SCIunshock, and SCIshock treated subjects at both 1 day
(p < 0.01, p < 0.001, and p < 0.05, respectively) and 7 days
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FIGURE 2 | Bar graphs depicting qRT-PCR analysis of miRNA expression
of miR1, miR21, miR124, miR129-2, and miR146a at the lesion site for
sham animals and after unshocked or shock treatment in contused
animals at 1 day following tailshock treatment.The x -axis denotes
treatment condition, and the y -axis denotes the log of mean fold expression
change of miRNA. Data are normalized relative to U6 small nuclear RNA
internal gene expression and expressed as the mean of all fold changes of
individual samples within a treatment group relative to the mean of the
treatment group (+SEM), with asterisks indicating signiﬁcance (LSD)
compared with sham controls and hash tags indicating signiﬁcance (LSD)
compared with contused unshocked controls; p values are as indicated in the
text.
following SCIunshock or SCIshock treatment (p < 0.01, p < 0.01,
and p < 0.001, respectively), and increased expression of IGF-
1 in SCIshock subjects at 7 days following SCIunshock or SCIshock
treatment (p < 0.005; Figures 5B,C).
Correlation analyses indicated that expression changes of multiple
SCI-sensitive miRNAs were associated with changes in BDNF and
IGF-1 expression
As BDNF and IGF-1 can be mRNA targets of miR1, we hypothe-
sized that a statistical relationship would exist between expression
changes in miR1 and that of BDNF and IGF-1. Pearson’s product–
moment correlations (combiningdata for dorsal and ventral spinal
cord and for day 1 and 7 post-shock) indicated two groups of sig-
niﬁcant correlations between SCI-sensitive miRNAs, BDNF, and
IGF-1. There were signiﬁcant correlations between BDNF and
both miR21 and miR124, and between IGF-1 and miR1, miR124,
and miR129-2 (Table 4). Additionally, BDNF and IGF-1 were also
signiﬁcantly, but inversely correlated with each other (Pearson’s
r = −0.31, p < 0.05).
We also used multivariate analyses to discover which miRNAs
accounted for a signiﬁcant proportion of the variance in IGF-1
and BDNF mRNA expression. For IGF-1, the analyses revealed
that miR124, miR21, and miR146a (in that order) each accounted
for an independent proportion of the variance (all Fs > 6.36,
p < 0.05), and together explained 42.3% of the variance. BDNF
mRNA expression was largely explained by miR21 and miR124
expression (both Fs > 7.57, p < 0.001), which together explained
24.8% of the variance. For both mRNAs, no other miRNA
independently explained a signiﬁcant proportion of variance.
DISCUSSION
One of the current clinical challenges with mitigating the short-
and long-term effects of spinal cord injury is managing the
uncontrollable nociception that results from concomitant periph-
eral tissue damage. It is critical for future efforts to develop
therapeutic strategies to attenuate glial activation, cell death,
and sensitization of spinal neurons associated with intermit-
tent noxious stimulation in order to inhibit maladaptive spinal
plasticity, improve functional recovery, and suppress pain hyper-
sensitivity following SCI with associated peripheral injuries (Liu
et al., 1999; Frei et al., 2000; Beattie et al., 2002; Hains et al.,
2003; Xu et al., 2004; Hains and Waxman, 2006; Lampert et al.,
2006; Detloff et al., 2008; Kuzhandaivel et al., 2011). Uncontrol-
lable nociception clearly inhibits functional recovery (Grau et al.,
2004; Garraway et al., 2011; Huie et al., 2012a). It is possible
that nociceptive stimuli may interfere with functional recovery
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FIGURE 3 | Bar graphs depicting qRT-PCR analysis of miRNA expression
of miR1, miR21, miR124, miR129-2, and miR146a at the lesion site for
sham animals and after unshocked or shock treatment in contused
animals at 7 days following tailshock treatment.The x -axis denotes
treatment condition, and the y -axis denotes the log of mean fold expression
change of miRNA. Data are normalized relative to U6 small nuclear RNA
internal gene expression and expressed as the mean of all fold changes of
individual samples within a treatment group relative to the mean of the
treatment group (+SEM), with asterisks indicating signiﬁcance (LSD)
compared with sham controls and hash tags indicating signiﬁcance (LSD)
compared with contused unshocked controls; p values are as indicated in the
text.
in part, by directly altering biology within damaged tissue at
the injury site. Speciﬁcally, it is possible that miRNAs, given
their dysregulation following SCI (Liu et al., 2009; Nakanishi
et al., 2010; Strickland et al., 2011, 2014; Bhalala et al., 2012)
and ability to coordinate the expression of large gene networks,
are involved in the modulation of nociceptive circuitry and
prevention of functional recovery resulting from uncontrollable
nociception. Therapeutic manipulation of these miRNAs could
alleviate the maladaptive effects of noxious stimulation in both
the acute and chronic phases of SCI by suppressing activa-
tion of glia-mediated inﬂammation and inhibiting the synaptic
remodeling of nociceptive circuitry that results in pain hyper-
sensitivity, increased spasticity, and exacerbation of behavioral
deﬁcits.
The current study investigated the regulation of SCI-sensitive
miRNAs at the site of an injury in rats administered uncontrollable
shock (SCIshock) or nothing (SCIunshock) 1 h, 1 day, or 7 days after
shock treatment. To examine the effect of a contusion injury per
se, we included a sham-operated unshocked control as a com-
parison group. We found that the contusion injury increased
expression of miR21 and miR146a at 1 h relative to the sham
control. In the unshocked rats, miR21 remained elevated in the
dorsal (at 1 day) and ventral (at 7 days) regions. In contused
shocked rats,miR21 remained elevated in both the dorsal and ven-
tral region across days (1 and 7). The change in miR146 appeared,
in contrast, to fade over days, with the only signiﬁcant increase
observed in the dorsal region of shocked rats at 1 day. At 1 day, the
contusion injury down-regulated miR1, miR124, and miR129-
2 in the ventral region of unshocked subjects. miR1 remained
down-regulated in the ventral region at 7 days and miR129-2 was
down-regulated in both the dorsal and ventral regions. Shocked
rats also showed a down-regulation ofmiR124 (dorsal and ventral)
andmiR129-2 (ventral) at 1 day. At 7 days, only shocked-contused
rats exhibited a signiﬁcant down-regulation of miR1 and miR124
in the dorsal region, whereas miR129-2 was down-regulated in
both regions. This overall pattern replicates key components of
our earlier study (Strickland et al., 2011), which showed that a
contusion injury down-regulatesmiR1,miR129, andmiR124, and
up-regulates miR21 and miR146a.
When we examined the effect of shock treatment on miRNA
expression in contused rats, we found that shock signiﬁcantly
decreased expression of miR124 in dorsal/sensory tissue at 1 day.
At 7 days, shock treatment signiﬁcantly increased the expression
of miR1 (ventral region) and miR129-2 (dorsal region), relative
to injured, unshocked controls. This is the ﬁrst evidence that
miRNA networks at the site of a contusion injury are affected
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FIGURE 4 | Correlation analyses to assess the relationship between
miR146a miRNA expression and expression of miR1, miR21, and
miR124 following SCI. Data for dorsal and ventral spinal cord and for day 1
and 7 post-shock were combined for analysis. (A)The x -axis and z -axis
represent the miRNAs of interest, and the y -axis depicts the magnitude of
the Pearson’s product–moment correlation coefﬁcient, r, between the
corresponding miRNAs indicated on the x - and z -axes. Pearson’s
correlations indicated seven statistically signiﬁcant relationships (p < 0.05;
black bars) and three non-signiﬁcant relationships (p > 0.05; white bars).
(B)The x -axis represents the mean difference in cycle threshold change
(−CT) between miRNA expression at both dorsal and ventral spinal cord
and at 1 and 7 days following tailshock treatment and U6 controls, and the
y-axis depicts the mean difference in cycle threshold change (−CT)
between miR146a expression in dorsal and ventral spinal cord and at both 1
and 7 days following tailshock treatment and U6 controls. Pearson’s
correlations indicated a signiﬁcant correlation between miR1 (black
diamonds), miR21 (white squares), and miR124 (gray triangles), and
miR146a (Pearson’s r = 0.59, P < 0.001, Pearson’s r = 0.69, P < 0.001,
and Pearson’s r = 0.39, P < 0.005, respectively). Data are represented as
the mean change in cycle threshold of miRNA expression relative to U6
controls (−CT = CTU6 − CTmiRNA).
by uncontrollable stimulation to distal spinal segments. Systemic
factors like inﬂammatory stimuli (Huie et al., 2012a) and the acti-
vation of glia (Vichaya et al., 2009)maymediate the effects of distal
uncontrollable stimulation on miRNA expression. However, the
direct involvement of intra-spinal circuitry cannot be eliminated.
Previous tract-tracing studies in the rat have described intra-spinal
proprioceptive circuits between the sacro-caudal spinal cord that
exerts sensorimotor control over the tail and more rostral spinal
levels including thoracic segments (Masson et al., 1991). More-
over, spinal cord trauma has also been previously shown to result
in extensive rewiring of intra-spinal circuitry (Bareyre et al., 2004)
in the rat. While rewired circuitry matures over a period of several
Table 3 | Pearson’s product–moment correlations for miRNA
expression.
miR1 miR21 miR124 miR129-2 miR146a
miR1
Pearson correlation 0.282* 0.575** 0.349** 0.589**
Sig. (two-tailed) 0.034 0.001 0.01 0.001
N 57 54 54 54
miR21
Pearson correlation 0.163 −0.155 0.691**
Sig. (two-tailed) 0.227 0.255 0.001
N 57 56 57
miR124
Pearson correlation 0.742** 0.394**






Analyses were based on combined data for both dorsal and ventral spinal cord
and at 1 and 7 days following tailshock treatment. For each correlation between
miRNAs given by row and column heading, the Pearson’s Correlation Coefﬁcient,
r, the p value based on Student’s two-tailed t-test, and the sample number, N, are
listed in order from top to bottom, respectively. Three main clusters of miRNAs
correlate signiﬁcantly together: miR1 correlates with miR21, miR124, miR129-
2, and miR146a, miR124 correlates with miR1, miR129-2, and miR146a, and
miR146a correlates with miR1, miR21, and miR124.
*Correlation is signiﬁcant at the 0.05 level (two-tailed).
**Correlation is signiﬁcant at the 0.01 level (two-tailed).
weeks following injury (Bareyre et al., 2004), a combination of
undamaged and early rewiring intra-spinal circuits may constitute
a mechanism whereby distal nociceptive stimuli regulate miRNA
expression at the injury site. Interestingly, shock treatment shifted
the regional distributionmiRNA expression in contused rats, lead-
ing to decreased expression of miR124 in the dorsal region and
at 7 days, a region-speciﬁc up-regulation of miR1 (ventral) and
miR129-2 (dorsal) relative to unshocked animals. In addition, dif-
ferences in expression of miR124 were accounted for by variation
in the expression of miR1, miR129-2, and miR146a, suggesting
that these miRNAs may be co-regulated. Collectively, these data
suggest that uncontrollable nociception modulates SCI-sensitive
miRNA networks in a spatially speciﬁc manner.
We observed that although there was initially signiﬁcant down-
regulation of IGF-1 following contusion, uncontrolled intermit-
tent shock did not immediately result in additional suppression
of Igf-1 at the 1-h time point. In contrast, IGF-1 was signif-
icantly increased in response to prior contusion at both 1 and
7 days following shock/unshock exposure, in both dorsal/sensory
and ventral/motor tissue. Interestingly uncontrollable intermit-
tent tailshock induced additional signiﬁcant up-regulation only
after a temporal delay, i.e, at 7 days after treatment, and only in the
dorsal (i.e., sensory) region of the spinal cord. These data suggest
Frontiers in Neural Circuits www.frontiersin.org September 2014 | Volume 8 | Article 117 | 8
Strickland et al. miRNAs and nociception in SCI
FIGURE 5 | Bar graphs depict qRT-PCR analysis of BDNF and IGF-1 mRNA
expression at the lesion site following shock treatment in contused
animals, compared to sham lesioned controls and non-shocked
(unshock), lesioned animals at 1 h (A), 1 day (B), or 7 days (C) following
tailshock treatment.The x -axis denotes treatment condition, and the y -axis
denotes the log of mean fold expression change of mRNA. Data were
normalized relative to GAPDH mRNA and expressed as the mean of fold
changes of individual samples within a treatment group relative to the mean
of the treatment group (+EM). As indicated in the text, there were signiﬁcant
main effects of time and spinal cord region (dorsal versus ventral) on mRNA
expression.Within each time group, asterisks indicate signiﬁcance (LSD)
compared with time-group speciﬁc sham controls and hash tags indicate
signiﬁcance (LSD) compared with contused unshocked controls; p values are
as indicated in the text.
that the IGF-1 response of the dorsal spinal cord ismore responsive
to nociceptive inﬂuences compared to the ventral spinal cord.
Table 4 | Pearson’s product–moment correlations between miRNA
expression and the expression of Igf1 and BDNF mRNA transcripts.
miR1 miR21 miR124 miR129-2 miR146a
BDNF mRNA
Pearson correlation 0.069 0.332** −0.289* −0.164 0.154
Sig. (two-tailed) 0.609 0.009 0.024 0.211 0.244
N 57 60 61 60 59
Igf1 mRNA
Pearson correlation 0.402** −0.235 0.469** 0.415** 0.173
Sig. (two-tailed) 0.002 0.071 0.001 0.001 0.189
N 57 60 61 60 59
Analysis was based on combined data for dorsal and ventral spinal cord and from
1 and 7 days following tailshock treatment. For each correlation betweenmiRNAs
given by row and column heading, the Pearson’s correlation coefﬁcient, r, the p
value based on Student’s two-tailed t-test, and the sample number, N, are listed
in order from top to bottom, respectively.
*Correlation is signiﬁcant at the 0.05 level (two-tailed).
**Correlation is signiﬁcant at the 0.01 level (two-tailed).
Consistent with our previous ﬁndings (Garraway et al., 2011),
we found that BDNF expression was signiﬁcantly down-regulated
at 1 day, as a function of SCI, but that uncontrollable inter-
mittent tail-shock resulted in additional and signiﬁcant BDNF
suppression, within the dorsal/sensory region of the spinal cord.
A step-wise linear regression analysis revealed that variation in
miR124, miR21, and miR146 accounted for a signiﬁcant propor-
tion of the variation in IGF-1 mRNA expression, and that miR21
and miR124 accounted for variation in BDNF mRNA expres-
sion, suggesting that both BDNF and IGF-1 regulation involves
a network of miRNAs. Alternatively, BDNF and IGF-1 may also
inﬂuence miRNA expression and the potential role of their down-
stream signaling cascades in inﬂuencing the expression of mR21
and miR124 need further investigation. The correlated expres-
sion of miRNA and trophic factor transcripts may also point to
the existence of positive feed-forward regulatory pathways. For
example, recent research has shown that another member of
the neurotrophin family, nerve growth factor (NGF) induces the
expression of miR21, and miR21 in turn promoted NGF-induced
neuronal differentiation (Montalban et al., 2014). Following SCI
such correlated trophic factor-miRNAnetworksmay be important
for promoting neuroprotection.
Surprisingly, though miR1 and IGF-1 were both responsive
to uncontrollable nociception variation in miR1 did not account
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for a signiﬁcant proportion of the variation in IGF-1 (or BDNF).
This surprising ﬁnding perhaps reﬂects physiological differences
between dorsal-sensory and ventral-motor spinal cord and their
association with nociceptive stimulation. At day 7 following
nociceptive/shock stimulation, miR1 expression in dorsal spinal
cord in animals that had only received SCI were not different
from controls, whereas IGF-1 mRNA expression was signiﬁcantly
increased. Uncontrollable nociception resulted in a signiﬁcant
decrease in miR1 while further increasing IGF-1 mRNA. There-
fore, in the dorsal, sensory spinal cord, nociceptive stimulation at
least resulted in a prototypic inverse relationship between miRNA
and target gene. Since the dorsal spinal cord is likely to be the
primary recipient of nociceptive input, the inverse relationship
between miR1 and IGF-1 may represent a direct sensory modula-
tionof SCI andSCI-sensitivemiRNA function. However, in ventral
spinal cord, at 7 days following uncontrollable shock, animals that
received SCI alone exhibited a signiﬁcant decrease in miR1 and
an increase in IGF1.While uncontrollable nociceptive stimulation
in SCI animals attenuated this decrease in miR1 observed follow-
ing SCI alone, effectively resulting in increasedmiRNA expression,
the expression of IGF-1 remained unchanged from the shock-only
condition. These data suggest a dissociation between miRNA and
target gene networks following SCI and intermittent noxious stim-
ulation, as we have previously observed in other models of neural
damage (Pappalardo-Carter et al., 2013). While such dissociation
may be simply the result of miRNA and mRNAs being expressed
in distinct and non-overlapping cell cohorts, this dissociation in
ventral spinal cord may be a secondary consequence of activating
the dorsal spinal cord. It is also intriguing to hypothesize that this
dissociation may indicate the emergence of intervening, compen-
satory biological mechanisms, including perhaps shifts in miRNA
function from translation repression to transcription activation
(Place et al., 2008; Liu et al., 2013).
Uncontrollable nociception may have signiﬁcant adverse con-
sequences for recovery of function, that may be mediated by
SCI-sensitive miRNAs. These miRNAs have also been shown
to be activated and to inﬂuence cellular responses to neuro-
pathic pain. For example, consistent with our own observation
showing delayed reduction in miR1, others have reported that
peripherally applied nociceptive and inﬂammatory stimuli also
result in long term reduction of miR1 expression in dorsal root
ganglia (Kusuda et al., 2011). An accumulating literature sug-
gests that several SCI-sensitive miRNAs control inﬂammatory and
other biological functions that are pertinent to nociception. For
example, miR124 suppresses activation of resting microglia and
macrophages prior to injury, and both miR21 and miR146a have
been shown to negatively regulate astrocyte activation following
SCI (Ponomarev et al., 2011; Bhalala et al., 2012; Iyer et al., 2012;
Willemen et al., 2012; Kynast et al., 2013). MiR124 is an espe-
cially important candidate, as it is involved in the regulation of
both BDNF and IGF-1, is sensitive to uncontrollable intermit-
tent tailshock, and has been shown to inhibit nociceptive behavior
associated with neuropathic pain (Kynast et al., 2013).While these
miRNA changes were assessed within the spinal cord, and pre-
sumably directly inﬂuenced by activation of neural nociceptive
pathways, the role of intermediate physiological and cellular acti-
vators cannot be ignored. For example, changes inheart rate, blood
pressure, or immune system activation in response to nociceptive
stimuli may mediate changes in miRNA expression. In this con-
text, it is important to note that miR1 is also highly expressed in
the vascular system and increases the barrier capacity of endothe-
lial cells (Wang et al., 2013). One prediction is that the persistent
decrease in miR1 expression following SCI may lead to increased
vascular permeability and consequently be permissive for leuko-
cyte inﬁltration. In the early stages of injury, the suppression of
miR1maywell have a protective effect, since the predicted increase
in leukocyte inﬁltration may limit tissue damage and promote
clearance of debris (Peruzzotti-Jametti et al., 2014). Uncontrol-
lable nociceptive stimuli may be predicted to prevent or delay that
effect.
SCI and nociception-sensitive target genes like IGF-1 also
have important consequences for functional recovery. IGF-1
promotes both oligodendrocyte survival after SCI upon up-
regulation through leukemia inhibitory factor-mediated activa-
tion of microglia (Kerr and Patterson, 2005; Mekhail et al.,
2012), and reduces blood–brain barrier permeability and edema
through attenuation of nitric oxide synthase up-regulation upon
its topical application prior to and following SCI (Sharma et al.,
1997; Nyberg and Sharma, 2002). IGF may have general neu-
roprotective value in a variety of disease models. For example,
recent research has shown that IGF-1 protects against ischemic
stroke (Selvamani et al., 2012). Intriguingly, in the above report,
antisense-mediated suppression of miR1 had the same neuro-
protective effect. These data suggest that the decrease in miR1
and increase in IGF-1 mRNA following SCI may represent a
neuroprotective adaptation. Conversely, uncontrollable nocicep-
tive stimulation effectively increases miR1 at least in dorsal
spinal cord, and may therefore adversely inﬂuence functional
recovery.
Collectively, these data suggest that SCI-sensitive miRNAs
constitute an important component of a response to uncontrol-
lable nociception from peripheral injury. While it remains to
be ascertained, these miRNAs and their targets may well engage
direct astrocyte- and glial-mediated mechanisms as well as indi-
rect inﬂammatory pathways. Consequently, these miRNAs may
constitute therapeutic targets for attenuating neuropathic pain
following SCI.
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